Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer
Clinical trial NCT04963595 · UNKNOWN
Trial details
- NCT number
- NCT04963595
- Sponsor
- Zhiyong Yu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-01
- Primary completion
- 2023-01-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.